Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism.

TSH levels achieved after one month of induced hypothyroidism (TSH_time1) were significantly correlated with age in univariate analysis.

• 102 patients with differentiated thyroid cancer (DTC) undergoing LT4 withdrawal prior to radioiodine administration were included, with a median age of 44 years.
• Age was significantly correlated with TSH_time1 (p = 0.005) in univariate analysis.
• The higher the age, the lower the TSH_time1 level, indicating that hypothalamic-pituitary thyrotropic activity (HPta) progressively reduces with age.

The dose of LT4 per kg per day taken prior to discontinuation was significantly associated with TSH levels achieved after induced hypothyroidism, representing a rebound effect.

• LT4 dose (dose pro Kg/die) was significantly correlated with TSH_time1 (p = 0.023) in univariate analysis.
• The higher the LT4_dose, the higher the TSH_time1 level.
• The authors describe this as a 'rebound effect of HPta,' reported for the first time, whereby prior LT4 suppression leads to greater TSH rebound upon withdrawal.

A multivariate model including age, BMI, LT4 dose, and systemic inflammation response index best explained variance in TSH_time1 after induced hypothyroidism.

• The fittest multivariate model included age, BMI, LT4_dose, and systemic inflammation response index (SIRI).
• The adjusted R² of this model was 0.4, indicating these variables together explained approximately 40% of the variance in TSH_time1.
• Mann-Whitney U-test and linear regression analyses were used in the statistical approach.
• Inflammation and metabolic status were identified as additional factors affecting hypothalamic-pituitary thyrotropic activity.

Hypothalamic-pituitary thyrotropic activity progressively reduces with age, which has implications for interpreting TSH values in elderly patients.

• The inverse relationship between age and TSH_time1 was identified in a controlled, standardized model of induced hypothyroidism using LT4 withdrawal.
• The authors state this age-related reduction in HPta 'must be considered when evaluating TSH values in the elderly.'
• The study used a standardized LT4 withdrawal protocol as a controlled model to isolate factors influencing HPta response.

The LT4 withdrawal protocol in DTC patients provided a standardized and controlled model for studying factors influencing hypothalamic-pituitary thyrotropic activity.

• Clinical and biochemical parameters were collected before LT4 discontinuation and after one month of induced hypothyroidism.
• Records were extracted from an institutional database of DTC patients undergoing LT4 withdrawal prior to radioiodine (RAI) administration.
• 102 patients were included in the final analysis with a median age of 44 years.
• The authors characterized this as a 'new model to better understand hypothyroidism,' as the controlled induction of hypothyroidism allowed isolation of variables influencing TSH response.